Evidence map›Paper›PMID 31942540›Full record

ArticleHemaSphere2019

Double Umbilical Cord Blood Transplantation in High-Risk Hematological Patients: A Phase II Study Focusing on the Mechanism of Graft Predominance.

Burak Kalin, Mariëtte Ter Borg, Rebecca Wijers, Judith A E Somers, Bronno van der Holt, Cornelis A M van Bergen, Eefke J Petersen, Jurgen Kuball, Ellen Meijer, Nicolaas P M Schaap and 6 more

Abstract readLetter
In one paragraph

Article in HemaSphere, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Burak KalinErasmus University Medical Center, Department of Hematology, Rotterdam, Netherlands.
Mariëtte Ter BorgErasmus University Medical Center, Department of Hematology, Rotterdam, Netherlands.
Rebecca WijersErasmus MC Cancer Institute, Laboratory of Tumor Immunology, Department of Medical Oncology, Rotterdam, Netherlands.
Judith A E SomersErasmus University Medical Center, Department of Hematology, Rotterdam, Netherlands.
Bronno van der HoltErasmus MC Cancer Institute, HOVON Data Center, Department of Hematology, Rotterdam, Netherlands.
Cornelis A M van BergenLeiden University Medical Center, Department of Hematology, Leiden, Netherlands.
Eefke J PetersenUniversity Medical Center Utrecht, Department of Hematology, Utrecht, Netherlands.
Jurgen KuballUniversity Medical Center Utrecht, Department of Hematology, Utrecht, Netherlands.
Ellen MeijerAmsterdam University Medical Center, VU Medical Center, Department of Hematology, Cancer Center Amsterdam, Amsterdam, Netherlands.
Nicolaas P M SchaapRadboud University Medical Center, Department of Hematology, Nijmegen.
Sacha S ZeerlederAmsterdam Medical Center, Department of Hematology, Amsterdam, Netherlands.
Annoek E BroersErasmus University Medical Center, Department of Hematology, Rotterdam, Netherlands.
Eric BraakmanErasmus University Medical Center, Department of Hematology, Rotterdam, Netherlands.
J H Frederik FalkenburgLeiden University Medical Center, Department of Hematology, Leiden, Netherlands.
Cor H J LamersErasmus MC Cancer Institute, Laboratory of Tumor Immunology, Department of Medical Oncology, Rotterdam, Netherlands.
Jan J CornelissenErasmus University Medical Center, Department of Hematology, Rotterdam, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31942540
PMCPMC6919462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.